When was Klotho Neurosciences, Inc. stock made available for the first time to the public?

The IPO date for Klotho Neurosciences, Inc. is currently unavailable. We're working on retrieving this information.

Where is the headquarters of Klotho Neurosciences, Inc. stock?

Headquarters of Klotho Neurosciences, Inc. is in US at 13576 Walnut Street, Omaha, NE 68144.

What industry does Klotho Neurosciences, Inc. belong to?

The Klotho Neurosciences, Inc. belongs to Biotechnology.

Klotho Neurosciences, Inc.

KLTOW•NASDAQ

Healthcare

Biotechnology

$0.23

$-0.02(-9.00%)

Klotho Neurosciences, Inc. (KLTOW) Company Profile & Overview

Explore Klotho Neurosciences, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Klotho Neurosciences, Inc. (KLTOW) Company Profile & Overview

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.

SectorHealthcare

IndustryBiotechnology

CEOJoseph Sinkule

Contact Information

https://klothoneuro.com

833 931 6330

13576 Walnut Street, Omaha, NE, 68144

Company Facts

3 Employees

CountryUS

Actively Trading

Frequently Asked Questions

;